Group 1 - The core viewpoint of the article highlights Huazhong Securities' buy rating for Niuwei Co., Ltd. (603699.SH) based on its strong financial performance and growth potential [1] - In Q2 2025, the company achieved a net profit margin of 20.49%, indicating an improvement in profitability [1] - Continuous investment in research and development has led to breakthroughs in high-end products across multiple fields [1] - The company is enhancing its upstream technical capabilities, with ongoing expansion in qualification certifications and customer coverage [1]

Core Viewpoint - Anke Biopharmaceuticals (安科生物) has been rated as a "Buy" by Huazhong Securities, highlighting its successful collaboration in BD (Business Development) and progress in innovative drug pipelines [1] Financial Performance - In the first half of 2025, Anke Biopharmaceuticals reported revenue of 1.292 billion yuan, a slight decrease of 0.51% year-on-year, and a net profit attributable to shareholders of 367 million yuan, down 11.92% year-on-year [1] - The company's non-recurring net profit was 342 million yuan, reflecting a year-on-year decline of 12.38% [1] Business Segments - The biopharmaceutical segment showed signs of recovery, achieving revenue of 969 million yuan, a year-on-year increase of 7.49% [2] - The first antibody drug, trastuzumab injection "Ansaiting," experienced rapid growth with sales increasing by 298% year-on-year, becoming a key driver of performance [2] - Traditional business segments faced challenges, with the Chinese medicine segment revenue at 145 million yuan, down 27.10% year-on-year, and the chemical synthesis drug segment at 72 million yuan, down 11.55% year-on-year [4] Strategic Collaborations - The company has made significant strides in BD collaborations, introducing two major long-acting products to enhance its market position in pediatric growth and assisted reproduction [3] - A strategic partnership with Weisheng Pharmaceutical was established for the long-acting growth hormone, which is expected to solidify the company's leading position in the growth hormone market [3] - An exclusive commercialization agreement was signed with Baoji Pharmaceutical for a long-acting follicle-stimulating hormone, anticipated to be the first of its kind in China [3] R&D and Innovation - Anke Biopharmaceuticals is advancing its innovative drug development, with several products in clinical trials, including a CAR-T cell therapy and an oncolytic virus therapy [5][6] - The company is also collaborating on a therapeutic mRNA vaccine for HPV-related precancerous lesions, currently in Phase Ib clinical trials [6] Future Outlook - The company has adjusted its revenue forecasts for 2025-2027, expecting revenues of 2.677 billion, 3.050 billion, and 3.529 billion yuan, with year-on-year growth rates of 5.6%, 13.9%, and 15.7% respectively [7] - Net profit forecasts for the same period are 756 million, 862 million, and 997 million yuan, with growth rates of 6.9%, 14.0%, and 15.6% respectively [7]

Core Viewpoint - The company, Ningbo Changyang Technology Co., Ltd., is under continuous supervision by Huazhong Securities as part of its stock issuance and listing process, which will last from November 8, 2023, to December 31, 2025 [1]. Continuous Supervision - Huazhong Securities has established and effectively implemented a continuous supervision work system and has signed a sponsorship agreement with Changyang Technology, clarifying the rights and obligations of both parties during the supervision period [2]. - The supervision includes daily communication, regular visits, on-site inspections, and due diligence to ensure compliance with laws and regulations [2]. - Any violations or breaches of commitments by the company or related parties must be reported to the Shanghai Stock Exchange within five working days [2]. Internal Control and Governance - The company is required to establish and effectively implement internal control systems, including financial management, accounting, and internal audit systems [4]. - Huazhong Securities has verified that Changyang Technology's internal control systems comply with relevant regulations and are effectively executed [4]. - The company must also establish a sound information disclosure system, ensuring that all submitted documents do not contain false records or misleading statements [4]. Financial Performance - For the first half of 2025, the company reported a net profit attributable to shareholders of -8.55 million yuan, a decrease of 150.11% year-on-year, primarily due to increased financial expenses and impairment losses on fixed assets [6][13]. - The company's operating income for the first half of 2025 was 647.03 million yuan, down 18.81% from the previous year [13]. - The basic earnings per share for the first half of 2025 was -0.03 yuan, reflecting a 150% decline compared to the previous year [13]. Core Competitiveness - The company has accumulated significant technological advantages in the development and production of special functional films, achieving domestic leading levels in core technologies [14]. - The company has a strong research and development focus, with a total of 452 patent applications, including 417 invention patents [16]. - The company emphasizes quality control, having established a comprehensive quality management system that meets international standards [19]. Research and Development - The company invested 29.44 million yuan in R&D in the first half of 2025, accounting for 5.60% of its operating income [20]. - The company has successfully developed various products, including reflective films and optical base films, which have achieved international leading quality [21]. - The company is also advancing projects related to CPI films, aiming to break the monopoly of foreign companies in this area [22]. Use of Raised Funds - As of June 30, 2025, the company has managed its raised funds in compliance with relevant regulations, with a remaining balance of 29.14 million yuan [22].

华安证券股份有限公司 关于宁波长阳科技股份有限公司 开展外汇套期保值业务的核查意见 华安证券股份有限公司（以下简称"保荐机构"、"华安证券"）作为宁波 长阳科技股份有限公司（以下简称"长阳科技"、"公司"）2022年度向特定对 象发行股票并上市持续督导工作的保荐机构，根据《证券发行上市保荐业务管理 办法》、 二、拟开展的套期保值业务概述 （一）业务品种 结合资金管理要求和日常经营需要，公司拟开展的金融衍生品套期保值业 务主要包括远期结售汇、外汇掉期、外汇互换及其他外汇衍生产品等业务。 《上海证券交易所科创板上市公司自律监管指引第1号——规范运作（2025 年5月修订）》等有关规定，对长阳科技开展外汇套期保值业务进行了核查，并 发表核查意见如下： 一、开展外汇套期保值业务的必要性 公司出口业务主要采用美元等外币进行结算，因此当汇率出现较大波动 时，汇兑损益将对公司的经营业绩造成一定影响，为有效规避外汇市场的风 险，防范汇率波动对公司经营业绩造成不利影响，提高外汇资金使用效率，合 理降低财务费用，公司拟与银行开展外汇套期保值业务。公司的外汇套期保值 业务以正常生产经营为基础，以规避和防范汇率风险为目的，不进行单纯 ...

Core Insights - The company, Shenzhen Akitamicro Electronics Co., Ltd., recently hosted a specific object research meeting with 17 institutions, including Huazhong Securities and Baoshi Investment, to discuss its business and product applications [1][2]. Group 1: Product Applications - The company's products have a wide range of applications, particularly in the automotive electronics sector, including instrument panels and central control systems, with clients such as Xuan Cai Shi Jia and partnerships with BYD and Changan for various vehicle models [2]. - In the smart home appliance sector, products are utilized in common appliances like refrigerators and air conditioners, while also having potential applications in smart robots, although the primary focus remains on non-consumer products [2]. Group 2: Collaboration and Business Operations - Currently, the company has not established partnerships with major players like Huawei and Tesla, and it has not disclosed the revenue contribution from BYD [2]. - The company does not have its own chip business and relies on externally sourced chips for its products [2]. Group 3: Electronic Paper Project - The electronic paper market shows significant growth potential, with a forecasted global market size of approximately $13 billion in 2024 and exceeding $20 billion by 2028, reflecting a compound annual growth rate of over 10% [2]. - The company has developed its electronic paper product production capabilities and is focusing on small to medium-sized product R&D, having collaborated with research institutions for key optical material development, and has achieved full-chain independent R&D with 32 patents filed, including 6 invention authorizations and 8 utility model authorizations as of December 31, 2024 [2]. Group 4: Financial Management and Future Outlook - Since its listing, the company has maintained annual cash dividends and aims to enhance its intrinsic value through these dividends [2]. - The company places a strong emphasis on accounts receivable management, reporting good quality and strong recoverability of its receivables [2]. - Looking ahead, the company plans to focus on its core business, align with policy and market demands, leverage its R&D system and technological foundation to drive product innovation and structural improvements, and expand application areas to reward investors [2].

Core Viewpoint - The report from Huazhong Securities indicates that Zhaoyi Innovation's net profit attributable to shareholders for the first half of 2025 reached 575 million yuan, representing a year-on-year increase of 11.31% [1] Financial Performance - In Q2 2025, the net profit attributable to shareholders was 341 million yuan, showing a year-on-year growth of 9.17% and a quarter-on-quarter increase of 45.27% [1] - The growth in profit is attributed to the implementation of consumer subsidies and the steady release of demand in consumer terminals, alongside the ongoing development of AI driving demand in PC, server, and automotive electronics sectors [1] Product Demand and Revenue Growth - In the Flash product segment, the demand in the consumer sector saw significant growth in the first half of 2025, driven by consumer subsidies and the peak consumption season in Q2 [1] - The continuous upgrade of NOR Flash storage capacity in mobile screens, AIPC, and servers has also contributed to the revenue growth in the Flash business [1] Chip Segment Performance - In the sensor chip segment, the company maintained relatively stable revenue year-on-year in the mobile market [1] - The revenue from analog chips experienced a year-on-year increase of over 450%, significantly boosted by the acquisition of Suzhou Saichip, leading to substantial growth in analog chip revenue [1] Investment Rating - The report maintains a "Buy" rating for the company [1]

华安证券研报指出，兆易创新2025年上半年归母净利润5.75亿元，同比增长11.31%，对应2Q25单季度 归母净利润3.41亿元，同比增长9.17%，环比增长45.27%。受益于消费类国家补贴政策的实施，消费终 端需求稳步释放，同时AI的发展持续拉动PC、服务器、汽车电子等领域需求增长。Flash产品方面， 2025年上半年，在消费国补及第二季度消费旺季等因素催化下，消费领域需求增长明显。同时，手机屏 幕、AIPC及服务器中NORFlash存储容量的不断升级也拉动了Flash业务收入的增长。传感器芯片方面， 公司在手机市场持续深耕，营收同比保持相对平稳。模拟芯片方面，公司原有模拟芯片收入实现同比超 过4.5倍的增长，加之收购苏州赛芯的影响，公司模拟芯片收入同比实现大幅增长。维持"买入"评级。 ...

Core Viewpoint - Haixing Electric's net profit for H1 2025 was 396 million yuan, a year-on-year decrease of 25.74%, while Q2 2025 net profit was 255 million yuan, down 20.16% year-on-year, attributed to demand fluctuations in certain overseas markets, although short-term disruptions do not alter long-term trends [1] Group 1: Financial Performance - Haixing Electric achieved a net profit of 396 million yuan in H1 2025, reflecting a 25.74% decline compared to the previous year [1] - In Q2 2025, the company reported a net profit of 255 million yuan, marking a 20.16% decrease year-on-year [1] Group 2: Business Development - In the overseas market, the company is focusing on "global layout and localized operation" to accelerate marketing channel deployment in key countries and new markets [1] - The South African smart ultrasonic water meter factory commenced operations during the reporting period [1] Group 3: Domestic Market Performance - The company enhanced its competitiveness in product and service offerings within the State Grid and Southern Grid [1] - Haixing Electric won a bid for 140 million yuan in the State Grid's electricity metering product procurement [1] - The company secured a total of 149 million yuan in bids for integrated products in the first batch of regional joint bidding for distribution networks [1] - In the Southern Grid's procurement for distribution equipment, the company won a bid worth 38.46 million yuan [1] - Additionally, it won a bid for 96.39 million yuan from Inner Mongolia Electric Power Group for marketing equipment [1] Group 4: New Energy Business - The company is accelerating the establishment of local operating entities and the digitalization of the WMS logistics system in key regions to build an efficient global supply chain collaboration system [1] - Haixing Electric is focusing on expanding its new energy channel business in Europe, Asia, Africa, and Latin America [1]

Core Viewpoint - HaiXing Electric's net profit for H1 2025 reached 396 million yuan, a year-on-year decrease of 25.74%, while Q2 2025 net profit was 255 million yuan, down 20.16% year-on-year, attributed to demand fluctuations in certain overseas markets, although short-term disruptions do not alter the long-term trend [1] Group 1: Financial Performance - In H1 2025, the company achieved a net profit of 396 million yuan, reflecting a year-on-year decline of 25.74% [1] - For Q2 2025, the net profit was 255 million yuan, showing a year-on-year decrease of 20.16% [1] Group 2: Business Development - In the overseas market, the company adheres to a strategy of "global layout and localized operation," accelerating the deployment of marketing channels in key countries, new markets, and new businesses [1] - The company's smart ultrasonic water meter factory in South Africa officially commenced operations during the reporting period [1] Group 3: Domestic Market Performance - The company continues to enhance its product and service competitiveness in the State Grid and Southern Grid [1] - The company won a bid for 140 million yuan in the State Grid's electricity metering product procurement [1] - In the first batch of regional joint bidding for distribution network products, the company secured a total of 149 million yuan for integrated products [1] - The company won a bid of 38.46 million yuan in the Southern Grid's distribution network equipment procurement [1] - In the Inner Mongolia Electric Power Group's marketing equipment bidding, the company won 96.39 million yuan [1] Group 4: New Energy Business - The company is accelerating the construction of local operating entities and a WMS warehousing logistics digital system in key regions, focusing on building an efficient collaborative global supply chain [1] - The company is promoting the penetration of new energy channel businesses in Europe, Asia, Africa, and Latin America [1] Group 5: Investment Rating - The company maintains a "buy" rating [1]

Market Performance - A-shares continued to be active on August 25, with the Shanghai Composite Index reaching a 10-year high, and trading volume exceeding 3 trillion yuan for the first time since October 8 of the previous year, marking only the second occurrence in A-share history [1] - The trading sentiment was robust, with a significant increase in the trading volume of the brokerage ETF (512000), which saw a peak increase of 2.5% before closing nearly 1% higher [1] Brokerage Sector Insights - The brokerage sector is benefiting from the rising market enthusiasm, with the brokerage ETF (512000) attracting a total of 2.083 billion yuan in inflows over the past week, bringing its total fund size to a record high of 29.679 billion yuan [1] - Positive earnings reports from the brokerage industry are emerging, with notable increases in net profits for several firms, including Guosheng Securities, which reported a 370% increase in net profit, and Huayin Securities, which saw a 172% year-on-year growth [3][4] Future Outlook - Analysts are optimistic about the brokerage sector's performance, with expectations of continued upward movement in the market, particularly in the short term [4] - The brokerage ETF (512000) is highlighted as an efficient investment tool, providing exposure to both leading brokerages and smaller firms with high growth potential [5]